產(chǎn)品編號 | bs-41256P |
英文名稱 | Recombinant human Myoglobin, Trx & His |
中文名稱 | 重組人肌紅蛋白 |
別 名 | MYO; MB; MGC13548; PVALB; MYG_HUMAN; Recombinant human Myoglobin, Trx & His |
理論分子量 | 17kDa |
檢測分子量 | 29 kDa |
性 狀 | Lyophilized or Liquid |
濃 度 | >0.5 mg/ml |
物 種 | Human |
序 列 | 1-154/154 |
純 度 | >95% as determined by SDS-PAGE |
純化方法 | AC |
內(nèi)毒素 | Not analyzed |
表達(dá)系統(tǒng) | E.coli |
活性 | Not tested |
標(biāo)簽 | Trx & His |
緩 沖 液 | 20 mM Tris-HCl (pH=9.0) with 170 mM NaCl, 1 mM EDTA and 0.03% proclin300 |
保存條件 | Stored at 2-8℃ for one year. |
注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
產(chǎn)品介紹 | Myoglobin is a small heme containing protein responsible for the oxygen deposition in muscle tissues. Only one form of myoglobin is expressed in cardiac and skeletal muscles. Myoglobin is known as a marker of myocardial damage and it has been used for more than three decades. Nowadays it still is very commonly used in clinical practice as an early marker of AMI. It appears in patient's blood 1 to 3 hours after onset of the symptoms, reaching peak level within 8 to 12 hours. Myoglobin is not so cardiac specific as cTnI or cTnT. Because of high myoglobin concentration in skeletal muscle tissue, even minor skeletal muscle injury results in the significant increase of myoglobin concentration in blood. Thus myoglobin is used together with cTnI or cTnT in clinical practise for better specificity in AMI diagnosis. SWISS: P02144 Gene ID: 4151 |
產(chǎn)品圖片 | |
我要詢價
*聯(lián)系方式:
(可以是QQ、MSN、電子郵箱、電話等,您的聯(lián)系方式不會被公開)
*內(nèi)容: